Anelyssa Cysne Frota D' Abreu, MD
Neurology · Grand Rapids, MINPI 1891243507
Payments from drug & device makers
What this record shows
Biogen accounts for 77.3% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for neurology clinicians in MI, where the typical reported total is $1,115.
Across 4 payments — averaging $49.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$152
- Eisai Inc.$45
Across 5 payments — averaging $235,273 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1M
- Biogen$138K
What the payments were for
- Food & beverage$11156%
- Education$8644%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 3 | $152 |
| Eisai Inc. | 1 | $45 |
How this compares
$197 in reported general payments places this provider in the 25th percentile of 652 neurology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rivastigmine | 52 | $5,973 |
| RivastigmineRivastigmine Tartrate | 48 | $2,713 |
| Donepezil Hcl | 251 | $2,347 |
| Sertraline Hcl | 194 | $1,510 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 45 | $1,068 |
| Duloxetine Hcl | 14 | $929 |
| Memantine Hcl | 29 | $757 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 24 | $655 |
| Bupropion XlBupropion Hcl | 32 | $580 |
| Buspirone Hcl | 35 | $339 |
| Mirtazapine | 32 | $297 |
| Fluoxetine Hcl | 31 | $275 |
| Escitalopram Oxalate | 27 | $241 |
| Trazodone Hcl | 44 | $205 |
Paid to pharmacies, not to this prescriber.
Other neurology in Grand Rapids
- Jared PomeroyGrand Rapids$329K
- Jessica HedemanGrand Rapids$167K
- Melanie TaylorGrand Rapids$91K
- Nicholas LannenGrand Rapids$58K
- Danette TaylorGrand Rapids$47K
- Aaron EllenbogenFarmington Hills$1.6M
- Matthew HoltzmanWayne$1.4M
- Richard TroschFarmington Hills$1.2M
- Wade CooperAnn Arbor$991K
- Bisena BulicaDetroit$900K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.